Anti-Mullerian hormone and its predictive value for assessing oocyte quality

Anti-Mullerian hormone and its predictive value for assessing oocyte quality

The article systematizes information on the diagnostic capabilities of modern clinical and laboratory markers of ovarian reserve. The diagnostic capabilities of anti-Mllerian hormone (AMH) as a marker of ovarian reserve are discussed, which make it possible to adjust the dose of hormonal drugs and p...

Full description

Bibliographic Details
Main Author:	Natalia V. Aleksandrova
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2020-12-01
Series:	Гинекология
Subjects:	oocyte quality ovarian stimulation ovarian reserve markers assisted reproductive technologies diagnostics
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/58504/41725

Similar Items

Association between decreased ovarian reserve and poor oocyte quality
by: Viviane Margareth Scantamburlo, et al.
Published: (2021-11-01)

Anti-Müllerian Hormone: A Personal View of the Empowering Analyte
by: Richard Fleming
Published: (2020-01-01)

Low Oocyte Maturity Rate and Asynchronous Follicle Development: Other Unnoticed Groups in the Bologna Criteria for Poor Responders?
by: Sinem Ertaş, et al.
Published: (2022-08-01)

Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation
by: Rachel B. Danis, M.D., M.S., et al.
Published: (2021-06-01)

Performance of anti‐Müllerian hormone (AMH) levels measured by Beckman Coulter Access AMH assay to predict oocyte yield following controlled ovarian stimulation for in vitro fertilization
by: Yoshimasa Asada, et al.
Published: (2019-07-01)

Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation
by: H. Saleh, et al.
Published: (2020-04-01)

Basal serum anti-müllerian hormone and antral follicle count are predictors of ovarian response for Asian women in Singapore
by: Lee Mee, et al.
Published: (2014-09-01)

Anti-Müllerian Hormone Related to Reproductive and Productive Longevity in Egyptian Buffaloes
by: Ghada H. Abdel- Rahman Hassan, et al.
Published: (2021-04-01)

The role of the growth hormone in assisted reproductive technologies cycles
by: Andrey Y Romanov, et al.
Published: (2019-08-01)

EFFECT OF OOCYTES QUALITY AND OVARIAN RESERVE ON THE THERAPEUTIC POTENTIAL OF IN VITRO FERTILIZATION IN PATIENTS OF LATE REPRODUCTIVE AGE
by: E. V. Krstic, et al.
Published: (2016-02-01)

Clinical Utilities of Anti-Müllerian Hormone
by: Nicole Russell, et al.
Published: (2022-12-01)

Anti-Müllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development
by: Akira Iwase, et al.
Published: (2023-11-01)

Effect of Melatonin on the Outcome of Assisted Reproductive Technique Cycles in Women with Diminished Ovarian Reserve: A Double-Blinded Randomized Clinical Trial
by: Bahia Namavar Jahromi, et al.
Published: (2017-01-01)

Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
by: Alessandro Conforti, et al.
Published: (2019-06-01)

The Clinical Value and Interpretation of Anti-Müllerian Hormone in Women With Cancer
by: Richard A. Anderson, et al.
Published: (2020-10-01)

Anti-Müllerian Hormone Predictive Levels to Determine The Likelihood of Ovarian Hyper-Response in Infertile Women with Polycystic Ovarian Morphology
by: Azadeh Akbari Sene, et al.
Published: (2021-04-01)

Anti-Mullerian Hormone Changes Following Laparoscopic Ovarian Cystectomy: A Prospective Comparative Study
by: Cho HY, et al.
Published: (2021-07-01)

Is the oocyte quality affected by endometriosis? A review of the literature
by: Ana Maria Sanchez, et al.
Published: (2017-07-01)

Follicle Stimulating Hormone and Anti-Müllerian Hormone among Fertile and Infertile Women in Ile-Ife, Nigeria: Is there A Difference?
by: Temitope Okunola, et al.
Published: (2017-04-01)

Impact of Maternal Age on Oocyte and Embryo Competence
by: Danilo Cimadomo, et al.
Published: (2018-06-01)

Establishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay
by: Nalini Mahajan, et al.
Published: (2019-01-01)

Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update
by: Huiyu Xu, et al.
Published: (2021-02-01)

Iraqi experience in the assessment of anti-Müllerian hormone utilization in clinical practice: An overview
by: Hanan Abdul Jabbar Al-Taee, et al.
Published: (2023-01-01)

Corifollitropin alfa in different variants of ovarian response in assisted reproductive technology programmes: literature review
by: A. G. Syrkasheva, et al.
Published: (2021-04-01)

Risk factors associated with changes in serum anti-Müllerian hormone levels before and after laparoscopic cystectomy for endometrioma
by: Chenyu Zhang, et al.
Published: (2024-03-01)

Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma
by: Jyoti Bala, et al.
Published: (2016-02-01)

Changes in anti-müllerian hormone after ultrasound guided aspiration and ethanol sclerotic therapy of ovarian cyst
by: Lulu Huang, et al.
Published: (2021-05-01)

Exposure of Early Postnatal Oocytes to Chemotherapy Alters the Potential Ovarian Reserve, According to an Ex Vivo Mouse Model
by: Meghan C. H. Ozcan, et al.
Published: (2023-12-01)

Effect of Superovulation Treatment on Oocyte’s DNA Methylation
by: Jordana S. Lopes, et al.
Published: (2022-12-01)

Different anti‐Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes
by: Rena Ishii, et al.
Published: (2019-07-01)

Editorial: Ovarian Stimulation, Endocrine Responses and Impact Factors Affecting the Outcome of IVF Treatment
by: Barbara Lawrenz, et al.
Published: (2022-04-01)

The Effects of Endometriosis on Ovarian Functions
by: Michio Kitajima, et al.
Published: (2021-06-01)

A role of anti-Mullerian hormone in external genital endometriosis
by: A. S. Molotkov, et al.
Published: (2021-05-01)

Age-specific distribution of serum anti-mullerian hormone and antral follicle count in Indian infertile women
by: Devika Gunasheela, et al.
Published: (2021-01-01)

Serum anti-Mullerian hormone predicts ovarian response in (Macaca fascicularis) monkeys
by: Hui Long, et al.
Published: (2018-10-01)

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
by: Panagiotis Drakopoulos, et al.
Published: (2019-02-01)

Editorial: GnRH agonist triggering of final oocyte maturation: Improving safety without compromising success
by: Johnny Awwad, et al.
Published: (2023-03-01)

Serum anti-Müllerian hormone (AMH) concentration during pregnancy: a longitudinal study
by: Sarah McCredie, et al.
Published: (2023-04-01)

Demographic, lifestyle, and reproductive determinants of serum anti-Müllerian hormone levels in adult women of reproductive age in Ilorin, North-Central Nigeria
by: Oyinkansola Islamiyat Lawal, et al.
Published: (2021-08-01)

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
by: Sandro C. Esteves, et al.
Published: (2018-08-01)